FULCRUM THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
FULCRUM THERAPEUTICS, INC. (FULC) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 40.64 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-09
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 40.64M shares, a 28.99% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 40.63K shares, a 47.48% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 36.61K shares, a 34.28% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 32.64K shares, a 36.82% increase year-over-year.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 35.36K shares, a 39.47% increase from fiscal 2020.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 25.35K shares, a 129.53% increase from fiscal 2019.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 11.05K shares, a 778.76% increase from fiscal 2018.
- FULCRUM THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 1.26K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | 40.64M shares 10-Q · filed 2022-05-09 | 20.34M shares derived: average of 2 quarters · filed 2022-05-09 | 13.57M shares derived: average of 3 quarters · filed 2022-05-09 | 10.19M shares derived: average of 4 quarters · filed 2022-05-09 | |
| 2021-12-31 | 40.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 38.62K shares derived: average of 2 quarters · filed 2022-03-03 | 36.63K shares derived: average of 3 quarters · filed 2022-03-03 | 35.36K shares 10-K · filed 2022-03-03 | |
| 2021-09-30 | 36.61K shares 10-Q · filed 2021-11-04 | 34.62K shares derived: average of 2 quarters · filed 2021-11-04 | 33.60K shares 10-Q · filed 2021-11-04 | 7.90M shares derived: average of 4 quarters · filed 2022-05-09 | |
| 2021-06-30 | 32.64K shares 10-Q · filed 2021-08-10 | 32.08K shares 10-Q · filed 2021-08-10 | 10.52M shares derived: average of 3 quarters · filed 2022-05-09 | 7.90M shares derived: average of 4 quarters · filed 2022-05-09 | |
| 2021-03-31 | 31.51M shares 10-Q · filed 2022-05-09 | 31.51K shares 10-Q · filed 2021-05-06 | 15.77M shares derived: average of 2 quarters · filed 2022-05-09 | 10.52M shares derived: average of 3 quarters · filed 2022-05-09 | 7.90M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | 27.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 27.41K shares derived: average of 2 quarters · filed 2022-03-03 | 26.22K shares derived: average of 3 quarters · filed 2022-03-03 | 25.35K shares 10-K · filed 2022-03-03 | |
| 2020-09-30 | 27.26K shares 10-Q · filed 2021-11-04 | 25.56K shares derived: average of 2 quarters · filed 2021-11-04 | 24.62K shares 10-Q · filed 2021-11-04 | 24.15K shares derived: average of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | 23.85K shares 10-Q · filed 2021-08-10 | 23.29K shares 10-Q · filed 2021-08-10 | 23.12K shares derived: average of 3 quarters · filed 2021-08-10 | 21.79K shares derived: average of 4 quarters · filed 2021-08-10 | |
| 2020-03-31 | 22.72K shares 10-Q · filed 2021-05-06 | 22.75K shares derived: average of 2 quarters · filed 2021-05-06 | 21.10K shares derived: average of 3 quarters · filed 2021-05-06 | 16.27K shares derived: average of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | 22.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | 20.29K shares derived: average of 2 quarters · filed 2021-03-04 | 14.12K shares derived: average of 3 quarters · filed 2021-03-04 | 11.05K shares 10-K · filed 2021-03-04 | |
| 2019-09-30 | 17.79K shares 10-Q · filed 2020-11-10 | 9.79K shares derived: average of 2 quarters · filed 2020-11-10 | 7.13K shares 10-Q · filed 2020-11-10 | 5.68K shares derived: average of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | 1.79K shares 10-Q · filed 2020-08-11 | 1.72K shares 10-Q · filed 2020-08-11 | 1.64K shares derived: average of 3 quarters · filed 2020-08-11 | 1.56K shares derived: average of 4 quarters · filed 2020-08-11 | |
| 2019-03-31 | 1.64K shares 10-Q · filed 2020-05-13 | 1.56K shares derived: average of 2 quarters · filed 2020-05-13 | 1.49K shares derived: average of 3 quarters · filed 2020-05-13 | 1.41K shares derived: average of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | 1.49K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | 1.41K shares derived: average of 2 quarters · filed 2020-03-05 | 1.34K shares derived: average of 3 quarters · filed 2020-03-05 | 1.26K shares 10-K · filed 2020-03-05 | |
| 2018-09-30 | 1.34K shares 10-Q · filed 2019-11-14 | 1.26K shares derived: average of 2 quarters · filed 2019-11-14 | 1.18K shares 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | 1.19K shares 10-Q · filed 2019-08-26 | 1.10K shares 10-Q · filed 2019-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |